Literature DB >> 30375252

Smilax china leaf extracts suppress pro-inflammatory adhesion response in human umbilical vein endothelial cells and proliferation of HeLa cells.

Clement O Tettey1, Injun Yang2, Heung-Mook Shin2,3.   

Abstract

Objective: The objective of this study was to investigate the anti-inflammatory and anticancer effects of the leaves of Smilax china.Methodology: The aqueous extract was examined for its anti-inflammatory effects on tumour necrosis factor (TNF)-α-induced inflammation in HUVECs whereas the aqueous (water), ethyl acetate (EA), butanol (B) and methylene chloride (MC) extracts were examined for their anticancer effect on HeLa cells.
Results: The aqueous extract suppressed the (TNF)-α-induced expression of ICAM-1, VCAM-1 and TNF-R1 and attenuated the expression of MCP-1, MMP-9, NF-kB and IFN-γ. The MC extract suppressed the proliferation of HeLa cells at all doses employed (50, 150, and 300 µg/ml). The EA extract demonstrated appreciable anti-proliferative effect whereas the BuOH extract demonstrated mild anti-proliferative activity. The aqueous extract did not show any significant anti-proliferative effect. None of the extracts were toxic to the normal cells (HUVECs).
Conclusion: Smilax china leaf extracts possess significant anti-inflammatory and anticancer effects.

Entities:  

Keywords:  HUVECs; Pro-inflammatory; Smilax china; anticancer; endothelium

Mesh:

Substances:

Year:  2018        PMID: 30375252     DOI: 10.1080/13813455.2018.1520262

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  2 in total

1.  The Anti-Inflammatory Effect of Smilax china L. Extract on LPS-Stimulated THP-1 via Downregulation of MAPK and NF-κB Signaling Pathway.

Authors:  Siyi Jiang; Qiong Wei; Xiaochuan Ye; Dan Luo; Xiaoyan Zhang; Zhenglei Li; Pengtao You; Xianzhang Huang; Yanwen Liu
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-16       Impact factor: 2.629

2.  Smilax china root extract as a novel Glucose- 6-phosphate dehydrogenase inhibitor for the treatment of hepatocellular carcinoma.

Authors:  Lubna Kanwal; Shaukat Ali; Azhar Rasul; Hafiz Muhammad Tahir
Journal:  Saudi J Biol Sci       Date:  2022-07-30       Impact factor: 4.052

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.